Results of Alimta (Pemetrexed) for Treatment of Malignant Pleural Mesothelioma Reported
Source: CancerConsultants.com
At the 12th World Conference on Lung Cancer held in Seoul, South Korea researchers presented the results of two separate studies analyzing the effectiveness of Alimta® for the treatment of malignant mesothelioma.
Researchers from Germany presented the results of an open-label study comparing Alimta alone to Alimta® + Platinol® (cisplatin) and to Alimta® + Paraplatin® (carboplatin). They found that all three treatments had a similar one year survival figure, but the combination of Alimta and a platinum compound caused a greater response than did treatment with Alimta alone. There was some concern that patient selection-bias had a negative affect on survival rates because previous studies have demonstrated a clear increase in survivability when combination theory was used over single agent therapy.
Researchers from the Netherlands presented the results of a study on patients previously treated for mesothelioma who were given an Altima regimen after their initial treatment. They found that previously treated patients can benefit from treatment with Alimta alone, Alimta with Platinol or Alimta with Paraplatin.
At the 12th World Conference on Lung Cancer held in Seoul, South Korea researchers presented the results of two separate studies analyzing the effectiveness of Alimta® for the treatment of malignant mesothelioma.
Researchers from Germany presented the results of an open-label study comparing Alimta alone to Alimta® + Platinol® (cisplatin) and to Alimta® + Paraplatin® (carboplatin). They found that all three treatments had a similar one year survival figure, but the combination of Alimta and a platinum compound caused a greater response than did treatment with Alimta alone. There was some concern that patient selection-bias had a negative affect on survival rates because previous studies have demonstrated a clear increase in survivability when combination theory was used over single agent therapy.
Researchers from the Netherlands presented the results of a study on patients previously treated for mesothelioma who were given an Altima regimen after their initial treatment. They found that previously treated patients can benefit from treatment with Alimta alone, Alimta with Platinol or Alimta with Paraplatin.
Labels: mesothelioma
posted by Belluck & Fox at
9:36 AM
© Belluck & Fox, L.L.P. All rights reserved.
